• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同群体对健康的重视程度:不丹一项基于人群的横断面支付意愿调查

Valuing health across groups: a cross-sectional population-based willingness-to-pay survey in Bhutan.

作者信息

Yao Ying, Rahman Md Mizanur, Teerawattananon Yot, Nakamura Ryota

机构信息

Faculty of Economics, Keio University, Tokyo, Japan.

Hitotsubashi Institute for Advanced Study, Hitotsubashi University, Tokyo, Japan.

出版信息

BMJ Glob Health. 2025 Aug 21;10(8):e019098. doi: 10.1136/bmjgh-2025-019098.

DOI:10.1136/bmjgh-2025-019098
PMID:40840968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12374658/
Abstract

INTRODUCTION

Context-specific cost-effectiveness thresholds (CETs) informed by societal willingness to pay (WTP) are crucial for healthcare resource allocation in low- and middle-income countries. This study investigated WTP for health per quality-adjusted life year (QALY) in Bhutan.

METHODS

A WTP survey was conducted alongside the 2023 National Health Survey in Bhutan, sampling 1869 households. Using contingent valuation, respondents assigned monetary values to three hypothetical scenarios: 1 year of cancer symptom-free life, 1 year of perfect health and 5 years of perfect health. We used generalised linear regression to estimate WTP, controlling for demographic, socioeconomic and health-related factors, as well as elicitation methods. Multilevel analyses examined WTP variations within and between districts.

RESULTS

WTP estimates were 76 836 Bhutanese ngultrum (BTN) (0.26 times gross domestic product (GDP) per capita; 95% CI: 71 397 to 82 275) for a year without cancer symptoms, 104 381 BTN (0.35 times GDP per capita; 95% CI: 96 405 to 112 357) for 1 QALY and 235 237 BTN (0.78 times GDP per capita; 95% CI: 218 674 to 251 800) for 5 QALYs. WTP variations were driven by within-district individual characteristics, particularly income and education, rather than between-district differences.

CONCLUSION

Minimal between-district WTP variations support a national-level CET for Bhutan. However, WTP-based CETs would be biased upward by wealthier and more educated groups. This bias could justify expensive technologies that strain public resources in Bhutan's government-funded healthcare system.

摘要

引言

基于社会支付意愿(WTP)的特定情境成本效益阈值(CET)对于低收入和中等收入国家的医疗资源分配至关重要。本研究调查了不丹每质量调整生命年(QALY)的健康支付意愿。

方法

在2023年不丹全国健康调查期间开展了一项支付意愿调查,对1869户家庭进行了抽样。采用条件估值法,让受访者为三种假设情景赋予货币价值:1年无癌症症状的生活、1年完全健康和5年完全健康。我们使用广义线性回归来估计支付意愿,控制人口统计学、社会经济和健康相关因素以及诱导方法。多层次分析考察了各地区内部和地区之间支付意愿的差异。

结果

无癌症症状一年的支付意愿估计值为76836不丹努尔特鲁姆(BTN)(人均国内生产总值(GDP)的0.26倍;95%置信区间:71397至82275),1个QALY的支付意愿为104381 BTN(人均GDP的0.35倍;95%置信区间:96405至112357),5个QALYs的支付意愿为235237 BTN(人均GDP的0.78倍;95%置信区间:218674至251800)。支付意愿的差异是由地区内部的个体特征驱动的,特别是收入和教育,而不是地区之间的差异。

结论

各地区之间支付意愿的差异最小,这支持了不丹的国家级成本效益阈值。然而,基于支付意愿的成本效益阈值会因较富裕和受教育程度较高的群体而向上偏差。这种偏差可能会使不丹政府资助的医疗系统中耗费公共资源的昂贵技术合理化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6855/12374658/4c8fd9a1dd2c/bmjgh-10-8-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6855/12374658/4c8fd9a1dd2c/bmjgh-10-8-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6855/12374658/4c8fd9a1dd2c/bmjgh-10-8-g001.jpg

相似文献

1
Valuing health across groups: a cross-sectional population-based willingness-to-pay survey in Bhutan.不同群体对健康的重视程度:不丹一项基于人群的横断面支付意愿调查
BMJ Glob Health. 2025 Aug 21;10(8):e019098. doi: 10.1136/bmjgh-2025-019098.
2
Willingness to pay for a quality-adjusted life year (QALY) in Pakistan: implications for health policy.巴基斯坦对质量调整生命年(QALY)的支付意愿:对卫生政策的影响。
Expert Rev Pharmacoecon Outcomes Res. 2025 Jul;25(6):967-975. doi: 10.1080/14737167.2025.2504945. Epub 2025 May 14.
3
A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?对获取每质量调整生命年支付意愿的研究进行的系统评价:这是否能证明成本效益阈值的合理性?
PLoS One. 2015 Apr 9;10(4):e0122760. doi: 10.1371/journal.pone.0122760. eCollection 2015.
4
How policymakers value end-of-life treatments for rare and common diseases in China: evidence from a contingent valuation study.中国政策制定者如何看待罕见病和常见疾病的临终治疗:一项条件价值评估研究的证据
Glob Health Res Policy. 2025 Aug 26;10(1):38. doi: 10.1186/s41256-025-00434-w.
5
Patient willingness to pay and preference for cervical cancer treatments among middle- and low-income populations in Xinjiang.新疆中低收入人群对宫颈癌治疗的支付意愿和偏好
J Patient Rep Outcomes. 2025 Aug 21;9(1):107. doi: 10.1186/s41687-025-00938-6.
6
The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.心脏再同步治疗(双心室起搏)用于心力衰竭的临床疗效及成本效益:系统评价与经济学模型
Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. doi: 10.3310/hta11470.
7
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
8
On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review.医疗成本效益阈值是基于什么设定的?相互冲突的观点和数据缺失:一项系统综述。
Glob Health Action. 2018;11(1):1447828. doi: 10.1080/16549716.2018.1447828.
9
Systematic Review of Willingness to Pay for Health Insurance in Low and Middle Income Countries.低收入和中等收入国家医疗保险支付意愿的系统评价
PLoS One. 2016 Jun 30;11(6):e0157470. doi: 10.1371/journal.pone.0157470. eCollection 2016.
10
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险

本文引用的文献

1
Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges.医疗保健公共政策中使用成本效益阈值:进展与挑战。
Appl Health Econ Health Policy. 2024 Nov;22(6):797-804. doi: 10.1007/s40258-024-00900-5. Epub 2024 Jul 12.
2
Establishing cost-effectiveness threshold in China: a community survey of willingness to pay for a healthylife year.在中国建立成本效益阈值:一项关于健康生活年支付意愿的社区调查。
BMJ Glob Health. 2024 Jan 9;9(1):e013070. doi: 10.1136/bmjgh-2023-013070.
3
Health-related quality of life among Indian population: The EQ-5D population norms for India.
印度人群的健康相关生活质量:印度 EQ-5D 人群正常值。
J Glob Health. 2023 Feb 17;13:04018. doi: 10.7189/jogh.13.04018.
4
Willingness to Pay for One Additional Quality Adjusted Life Year: A Population Based Survey from China.支付意愿以获得额外一年质量调整生命年:来自中国的一项基于人群的调查。
Appl Health Econ Health Policy. 2022 Nov;20(6):893-904. doi: 10.1007/s40258-022-00750-z. Epub 2022 Aug 8.
5
Estimating the range of incremental cost-effectiveness thresholds for healthcare based on willingness to pay and GDP per capita: A systematic review.基于支付意愿和人均 GDP 估算医疗保健增量成本效益阈值范围:系统评价。
PLoS One. 2022 Apr 14;17(4):e0266934. doi: 10.1371/journal.pone.0266934. eCollection 2022.
6
The Use of Cost-Effectiveness Thresholds for Evaluating Health Interventions in Low- and Middle-Income Countries From 2015 to 2020: A Review.2015 年至 2020 年期间,用于评估中低收入国家卫生干预措施的成本效益阈值:综述。
Value Health. 2022 Mar;25(3):385-389. doi: 10.1016/j.jval.2021.08.014. Epub 2021 Oct 29.
7
Determinants of willingness to pay for health services: a systematic review of contingent valuation studies.支付意愿影响因素的研究:基于条件价值评估法的系统综述
Eur J Health Econ. 2022 Dec;23(9):1455-1482. doi: 10.1007/s10198-022-01437-x. Epub 2022 Feb 15.
8
A Contingent Valuation Study for Eliciting a Monetary Value of a Quality-Adjusted Life-Year in the General Greek Population.对一般希腊人群体进行质量调整生命年货币价值的条件价值评估研究。
Value Health Reg Issues. 2020 Sep;22:36-43. doi: 10.1016/j.vhri.2020.03.002. Epub 2020 Jul 27.
9
Economic evaluation of rotavirus vaccination in children of Bhutan.不丹儿童轮状病毒疫苗接种的经济评价。
Vaccine. 2020 Jul 6;38(32):5049-5059. doi: 10.1016/j.vaccine.2020.05.035. Epub 2020 Jun 7.
10
Discounting in Economic Evaluations.经济性评价中的折扣
Pharmacoeconomics. 2018 Jul;36(7):745-758. doi: 10.1007/s40273-018-0672-z.